By Mark Waghorn via SWNS A drug that destroys the deadliest brain tumors has been developed by scientists. It passes through the blood-brain barrier that protects neurons from […]
Scientists create drug that destroys deadly brain tumors Read More »
A 66-year-old man who was diagnosed with HIV in 1988 is said to be free of both the HIV virus and cancer, following a stem
Man cured of HIV, cancer following breakthrough stem cell transplant: Doctors Read More »
A new cancer therapy has proven successful, as the therapy’s first patient has been in remission since June of 2021. The patient, John Hornsby Sr.
First patient to try revolutionary new cancer therapy is in remission Read More »
It was 2010, and 5-year-old Emily Whitehead had her entire future ahead of her. “From the time she was little, she liked to pull pranks
Teen Is Cured from Cancer After Groundbreaking Therapy: ‘It’s a Miracle I’m Alive’ Read More »
A cancer cell is an aberration as anomalous as a version of the Miguel Cervantes classic, Don Quixote of La Mancha, with the opening line
Personalized treatments for the deadliest cancers could be on the horizon after scientists discovered what makes them grow and spread. They are fueled by a
Personalized treatments for the deadliest cancers on horizon Read More »
MGC Pharmaceuticals (LON: MXC), a publicly-traded cannabis company, recently finalized pre-clinical trial research of cannabinoids as a potential treatment for glioblastoma, an aggressive brain cancer. The results were positive, reported CityA.M. The European-based
CBD And CBG Show Promising Results In Treating Glioblastoma Brain Tumors Read More »
Experts have hailed a cutting-edge vaccine that could prevent pancreatic cancer from returning. Early trial results suggest the personalized vaccines prime the body to stop
New vaccine could prevent deadliest cancer returning Read More »
A medical trial for a treatment of a specific type of cancer, received an unprecedented 100% success rate, with all participating patients in remission, according
Small N.Y. cancer trial attains 100% remission rate Read More »
Dr. Scott Gottlieb, former FDA commissioner, discusses the top drug trial data coming out of the American Society of Clinical Oncology conference in Chicago. posted
Promising new cancer drug data: ‘The future is here’ Read More »
More than 40% of patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC) responded to treatment with adagrasib, findings from a phase II trial showed. Among 112
KRAS Inhibitor Shrinks Tumors in Over 40% of NSCLC Patients Read More »
Johnson & Johnson and AbbVie’s big-selling leukemia drug Imbruvica in combination with standard treatment kept a rare type of non-Hodgkin lymphoma in check for more
J&J, AbbVie cancer drug significantly slows progression of rare lymphoma: study Read More »
